JP2011511622A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011511622A5 JP2011511622A5 JP2010541803A JP2010541803A JP2011511622A5 JP 2011511622 A5 JP2011511622 A5 JP 2011511622A5 JP 2010541803 A JP2010541803 A JP 2010541803A JP 2010541803 A JP2010541803 A JP 2010541803A JP 2011511622 A5 JP2011511622 A5 JP 2011511622A5
- Authority
- JP
- Japan
- Prior art keywords
- qpct
- human animal
- mouse
- model
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 claims 12
- 101150035356 Qpct gene Proteins 0.000 claims 10
- 238000000034 method Methods 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 9
- 241000699666 Mus <mouse, genus> Species 0.000 claims 8
- 238000010171 animal model Methods 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 238000012216 screening Methods 0.000 claims 7
- 241001465754 Metazoa Species 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 3
- 208000037803 restenosis Diseases 0.000 claims 3
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims 2
- 208000023697 ABri amyloidosis Diseases 0.000 claims 2
- 208000017227 ADan amyloidosis Diseases 0.000 claims 2
- 108700028369 Alleles Proteins 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 201000010374 Down Syndrome Diseases 0.000 claims 2
- 201000000162 ITM2B-related cerebral amyloid angiopathy 1 Diseases 0.000 claims 2
- 201000000194 ITM2B-related cerebral amyloid angiopathy 2 Diseases 0.000 claims 2
- 206010033645 Pancreatitis Diseases 0.000 claims 2
- 241001323319 Psen Species 0.000 claims 2
- 241000700159 Rattus Species 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 208000010877 cognitive disease Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 208000027061 mild cognitive impairment Diseases 0.000 claims 2
- 230000035772 mutation Effects 0.000 claims 2
- 230000004770 neurodegeneration Effects 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 claims 2
- 238000013279 ApoE knockout mouse model Methods 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 108700024394 Exon Proteins 0.000 claims 1
- 208000009386 Experimental Arthritis Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 241000699670 Mus sp. Species 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 238000006555 catalytic reaction Methods 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 230000030505 negative regulation of chemotaxis Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000035790 physiological processes and functions Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000011552 rat model Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2078408P | 2008-01-14 | 2008-01-14 | |
| PCT/EP2009/050387 WO2009090190A1 (en) | 2008-01-14 | 2009-01-14 | Mouse models carrying a knock-out mutation of the glutaminyl cyclase gene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011511622A JP2011511622A (ja) | 2011-04-14 |
| JP2011511622A5 true JP2011511622A5 (enExample) | 2012-03-01 |
Family
ID=40427980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010541803A Pending JP2011511622A (ja) | 2008-01-14 | 2009-01-14 | グルタミニルシクラーゼ遺伝子のノックアウト変異を有するマウスモデル |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9462793B2 (enExample) |
| EP (1) | EP2238252B1 (enExample) |
| JP (1) | JP2011511622A (enExample) |
| AU (1) | AU2009204864A1 (enExample) |
| CA (1) | CA2710494A1 (enExample) |
| IL (1) | IL206484A0 (enExample) |
| NZ (1) | NZ586665A (enExample) |
| WO (1) | WO2009090190A1 (enExample) |
| ZA (1) | ZA201004367B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3174987B1 (en) * | 2014-08-01 | 2023-10-11 | The Johns Hopkins University | Mrgprx2/mrgprb2 expressing cell based assay to detect pseudo-allergic drug reactions and to identify blockers to prevent the adverse reactions |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| JP2874751B2 (ja) | 1986-04-09 | 1999-03-24 | ジェンザイム・コーポレーション | 希望する蛋白質をミルク中へ分泌する遺伝子移植動物 |
| US4873316A (en) | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| GB8901778D0 (en) | 1989-01-27 | 1989-03-15 | Univ Court Of The University O | Manipulatory technique |
| US5602299A (en) | 1992-09-23 | 1997-02-11 | Mount Sinai School Of Medicine Of The City University Of New York | Transgenic animal models for neurodegenerative disease |
| JPH07132033A (ja) | 1993-11-12 | 1995-05-23 | Hoechst Japan Ltd | アルツハイマー病モデルトランスジェニック動物 |
| US6066778A (en) | 1996-11-06 | 2000-05-23 | The Regents Of The University Of Michigan | Transgenic mice expressing APC resistant factor V |
| US5981830A (en) | 1997-05-30 | 1999-11-09 | Schering Aktiengesellschaft | Knockout mice and their progeny with a disrupted hepsin gene |
| US20030013177A1 (en) | 2001-05-23 | 2003-01-16 | Ebens Allen J. | Polynucleotides encoding insect glutaminyl cyclase and uses thereof |
| US6948038B2 (en) * | 2001-07-24 | 2005-09-20 | Microsoft Corporation | System and method for backing up and restoring data |
| MXPA05011861A (es) | 2003-05-05 | 2006-02-17 | Probiodrug Ag | Uso de efectores de ciclasas de glutamato y glutaminil. |
| US7371871B2 (en) | 2003-05-05 | 2008-05-13 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| US8338120B2 (en) | 2003-05-05 | 2012-12-25 | Probiodrug Ag | Method of treating inflammation with glutaminyl cyclase inhibitors |
| NZ572274A (en) | 2003-05-05 | 2009-06-26 | Probiodrug Ag | Use of effectors of glutaminyl and glutamate cyclases |
| EA010108B1 (ru) | 2003-10-15 | 2008-06-30 | Пробиодруг Аг | Применение эффекторов глутаминил- и глутаматциклаз |
| CA2544573A1 (en) | 2003-11-03 | 2005-06-02 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
| US20050171112A1 (en) | 2003-11-03 | 2005-08-04 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
| US7667044B2 (en) | 2003-11-03 | 2010-02-23 | Probiodrug Ag | Compounds for the treatment of neurological disorders |
| KR101099206B1 (ko) | 2004-02-05 | 2011-12-27 | 프로비오드룩 아게 | 신규한 글루타미닐 시클라제 저해제 |
| US20080249083A1 (en) * | 2006-09-21 | 2008-10-09 | Probiodrug Ag | Novel genes related to glutaminyl cyclase |
| US8420684B2 (en) | 2006-11-09 | 2013-04-16 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| US7741354B2 (en) | 2006-11-09 | 2010-06-22 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| EP2091948B1 (en) | 2006-11-30 | 2012-04-18 | Probiodrug AG | Novel inhibitors of glutaminyl cyclase |
| HRP20110651T1 (hr) | 2007-01-19 | 2011-10-31 | Probiodrug Ag | Modeli pretraživanja in vivo radi liječenja alzheimerove bolesti i drugih poremećaja povezanih s qpct |
| US7803810B2 (en) | 2007-03-09 | 2010-09-28 | Probiodrug Ag | Inhibitors |
| US8772508B2 (en) | 2007-04-18 | 2014-07-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| WO2008128982A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors |
| US9512082B2 (en) | 2007-04-18 | 2016-12-06 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| DK2160380T3 (da) | 2007-04-18 | 2014-06-30 | Probiodrug Ag | Cyano-guanidin derivater som glutaminyl cyclase inhibitorer |
| US8202897B2 (en) | 2007-04-18 | 2012-06-19 | Probiodrug Ag | Inhibitors of glutaminyl cyclases |
| US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| JP5676249B2 (ja) | 2007-04-20 | 2015-02-25 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのアミノピリジン誘導体 |
| EP2195336B1 (en) | 2007-09-12 | 2015-01-21 | Probiodrug AG | Transgenic mice |
-
2009
- 2009-01-14 EP EP09702062.2A patent/EP2238252B1/en not_active Not-in-force
- 2009-01-14 AU AU2009204864A patent/AU2009204864A1/en not_active Abandoned
- 2009-01-14 WO PCT/EP2009/050387 patent/WO2009090190A1/en not_active Ceased
- 2009-01-14 JP JP2010541803A patent/JP2011511622A/ja active Pending
- 2009-01-14 NZ NZ586665A patent/NZ586665A/en not_active IP Right Cessation
- 2009-01-14 CA CA2710494A patent/CA2710494A1/en not_active Abandoned
- 2009-01-14 US US12/353,463 patent/US9462793B2/en not_active Expired - Fee Related
-
2010
- 2010-06-20 IL IL206484A patent/IL206484A0/en unknown
- 2010-06-21 ZA ZA2010/04367A patent/ZA201004367B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schinke et al. | Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen | |
| Tunquist et al. | Loss of AKAP150 perturbs distinct neuronal processes in mice | |
| Xu et al. | mGluR5 has a critical role in inhibitory learning | |
| Caravia et al. | The microRNA-29/PGC1α regulatory axis is critical for metabolic control of cardiac function | |
| Yamada et al. | Promoter decommissioning by the NuRD chromatin remodeling complex triggers synaptic connectivity in the mammalian brain | |
| Wu et al. | The tissue plasminogen activator (tPA/Plasmin) extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate | |
| Patrakka et al. | Nephrin–a unique structural and signaling protein of the kidney filter | |
| Kapoor et al. | An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval | |
| Takaluoma et al. | Tissue-specific changes in the hydroxylysine content and cross-links of collagens and alterations in fibril morphology in lysyl hydroxylase 1 knock-out mice | |
| Logue et al. | The orphan GPCR, GPR88, modulates function of the striatal dopamine system: a possible therapeutic target for psychiatric disorders? | |
| Hu et al. | Mesenchymal deficiency of Notch1 attenuates bleomycin-induced pulmonary fibrosis | |
| JP2015523863A5 (enExample) | ||
| Lehre et al. | Deletion of the betaine–GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult mice | |
| JP2010516235A5 (enExample) | ||
| Park et al. | Deficits in Col5a2 expression result in novel skin and adipose abnormalities and predisposition to aortic aneurysms and dissections | |
| Duverger et al. | In vivo impact of Dlx3 conditional inactivation in neural crest‐derived craniofacial bones | |
| JP2025063048A (ja) | 神経の疾患を検出し、予防し、回復に向かわせ、治療する方法 | |
| Ichinose et al. | Development of a highly potent analogue and a long-acting analogue of oxytocin for the treatment of social impairment-like behaviors | |
| Paone et al. | Genetics of cardiovascular disease: fishing for causality | |
| Pata et al. | Ostm1 bifunctional roles in osteoclast maturation: insights from a mouse model mimicking a human OSTM1 mutation | |
| Moura Santos et al. | Chronic overexpression of angiotensin-(1-7) in rats reduces cardiac reactivity to acute stress and dampens anxious behavior | |
| Chang et al. | Identification of Astrotactin2 as a genetic modifier that regulates the global orientation of mammalian hair follicles | |
| Kassab et al. | Mitochondrial arrest on the microtubule highway—a feature of heart failure and diabetic cardiomyopathy? | |
| Schilling et al. | Glutaminyl cyclase knock-out mice exhibit slight hypothyroidism but no hypogonadism: implications for enzyme function and drug development | |
| Yang et al. | cdh23 affects congenital hearing loss through regulating purine metabolism |